Skip to content

Treatment of Benign Prostatic Hyperplasia using Varunadya Taila Matra Basti and Trikatu Gutika.

Comparative Evaluation of Varunadya Taila Matra Basti and Trikatu Gutika in Vatashtheela (Benign Prostatic Hyperplasia). - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095055
Enrollment
36
Registered
2025-09-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms Health Condition 2: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Sponsors

Uttarakhand Ayurved University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age-50 or above 50 years. Sex - Male Patients with classical signs & symptoms of Vatashtheela.

Exclusion criteria

Exclusion criteria: Age below 50 years. Patient with acute retention. Known Malignant condition of Uro-genital system. Patient associated with other systemic disorders- Renal Failure, immune-compromised patients, etc. Patient not willing to undergo trial.

Design outcomes

Primary

MeasureTime frame
Relief in the symptoms like frequency of urination in day and night time, urgency of urination & relief in signs such as enlargement of Prostate.Timepoint: Zero, 7th, 14th, 21st day and after treatment.

Secondary

MeasureTime frame
Expected improvement in the quality of life of patients by relief in the symptoms like decrease in the frequency of Micturition by patient during day & night, Urgency, as well as expected relief in reduction of size of Prostate gland.Timepoint: Zero 7th 14th 21st day & after treatment

Countries

India

Contacts

Public ContactSakshi Bisht

Rishikul Campus, Haridwar.

akg1409@gmail.com9412856414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026